MannKind Corporation
NASDAQ:MNKDBiotechnology
Healthcare
$3.95 -0.51%
-$0.02 today
- Market cap
- $1.27B
- Beta
- 1.11
- P/E (TTM)
- -50.3
- EPS (TTM)
- -$0.08
52W Low $2.23High $6.51
Volume 4.08M
Average 5.73M
Income Statement
Follow revenue through to earnings.
Revenue
$348.97M
FY 2025 · Annual
+22.2% YoYOperating Income
$38.80M
FY 2025 · Annual
-46.5% YoYNet Income
$5.86M
FY 2025 · Annual
-78.7% YoYIncome Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 75.44M | 99.77M | 198.96M | 285.5M | 348.97M |
| Cost of Revenue | 38.86M | 57.5M | 62.77M | 76.6M | 61.16M |
| Gross Profit | 36.59M | 42.27M | 136.19M | 208.9M | 287.81M |
| Gross Margin | 48.5% | 42.4% | 68.5% | 73.2% | 82.5% |
| Research & Development | 12.31M | 19.72M | 31.28M | 45.89M | 66.35M |
| Selling, General & Admin | 77.42M | 91.47M | 94.31M | 94.33M | 144.14M |
| Operating Expenses | 83.61M | 106.38M | 127.51M | 136.32M | 249.01M |
| Depreciation & Amortization | 3.24M | 6.31M | 4.54M | 8.97M | 12.28M |
| EBITDA | (61.11M) | (56.32M) | 15.13M | 77.47M | 27.52M |
| EBITDA Margin | -81.0% | -56.4% | 7.6% | 27.1% | 7.9% |
| Operating Income | (47.02M) | (64.11M) | 8.68M | 72.59M | 38.8M |
| Operating Margin | -62.3% | -64.3% | 4.4% | 25.4% | 11.1% |
| Interest Income | 112K | 2.51M | 6.15M | 12.62M | 0 |
| Interest Expense | 16.58M | 24.77M | 25.16M | 37.98M | 13.83M |
| Other Income / Expenses | (33.9M) | (23.29M) | (19.06M) | (42.07M) | (37.39M) |
| Income Before Tax | (80.93M) | (87.4M) | (10.38M) | 30.52M | 1.41M |
| Pre-Tax Margin | -107.3% | -87.6% | -5.2% | 10.7% | 0.4% |
| Income Tax Expense | 0 | 0 | 1.56M | 2.93M | (4.46M) |
| Net Income | (80.93M) | (87.4M) | (11.94M) | 27.59M | 5.86M |
| Net Margin | -107.3% | -87.6% | -6.0% | 9.7% | 1.7% |
| EPS (Basic) | (0.37) | (0.44) | (0.04) | 0.10 | 0.02 |
| EPS (Diluted) | (0.37) | (0.44) | (0.04) | 0.10 | 0.02 |
| 249.24M | 257.09M | 267.01M | 274.42M | 305.64M | |
| 249.24M | 257.09M | 267.01M | 283.84M | 314.11M |
MNKD Earnings Waterfall · TTM
NASDAQ:MNKD · Revenue to Net Income
Key Ratios
EPS$-0.08
Gross Margin75.7%
Net Margin-5.5%
P/E Ratio110.0
P/S Ratio14.7
Analysis
$360.8M of revenue converted into -$23.9M of net income for the selected period. Gross margin is 75.7% and net margin is -5.5%, showing how much revenue survives after costs and taxes. EPS is $-0.08, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| SC 13G | SC 13G filing | Nov 10, 2026 | |
| 10-Q | Quarterly report | Nov 5, 2026 | |
| 8-K | Current report | Nov 5, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 28, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 14, 2026 |
How much revenue does MNKD generate?
MannKind Corporation (MNKD) reported $348.97M of revenue in fiscal 2025.
Is MNKD profitable?
MannKind Corporation (MNKD) reported $5.86M of net income, with a net margin of 1.7%.
Continue the stock analysis
Jump to another research area for this company.